Mosaic Biosciences, Inc.
New Form D on file · 2026-11-19 · the record
Before you sell to, join or invest in Mosaic Biosciences, Inc.
MentionFox check on Mosaic Biosciences, Inc.: only 1 source on file so far (checked 20 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/mosaic-biosciences-inc-form-d-000004
Check Mosaic Biosciences, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Mosaic Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-19.
Mosaic Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 19, 2026. The filing reports $3M sold. Its industry group is Biotechnology. It names Martin Stanton (Director), Eric Furfine (Executive Officer, Director), Dan Mitchell (Director) (SEC Form D, November 19, 2026).
Sell to companies like Mosaic Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Mosaic Biosciences, Inc. raised on Nov 19. 137 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Linework USA INC. | $1.2B | AI and software |
| Linework USA INC. | $326M | AI and software |
| Pathos AI, Inc. | $238M | Biotech |
| Galvanize Therapeutics, Inc. | $136M | Biotech |
| Tractian Inc. | $106M | AI and software |
Selling to Mosaic Biosciences, Inc.? See who runs it and how to reach them, plus this week's 161 other newly funded companies.
Is this your company?
New Form D on file · 2026-11-19 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Mosaic Biosciences, Inc.
Free to see. No signup.
More on the people and the money behind Mosaic Biosciences, Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Mosaic Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Mosaic Biosciences, Inc. raises, hires or launches. No email unless you switch it on.
Watch Mosaic Biosciences, Inc. →Get the full cited report on Mosaic Biosciences, Inc.
What the filing shows about Mosaic Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Mosaic Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The weeks after a raise are when investors, other founders and press look Mosaic Biosciences, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Mosaic Biosciences, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.
The filing gives Mosaic Biosciences, Inc.'s address as 5710 Flatirons Parkway, Boulder, CO 80301.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Mosaic Biosciences, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Mosaic Biosciences, Inc. See pricing
Mosaic Biosciences, Inc. is a registered filer with the SEC (CIK 1526054) and has filed since 2023-01-06. 2 filings are on record, the latest on 2026-11-19.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Mosaic Biosciences, Inc.'s Form D of 2026-11-19 names Martin Stanton, Eric Furfine, Dan Mitchell and 5 more as its officers, directors or promoters.
Its new offerings report $14.38M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 760 filings in Biotechnology, totalled by week. The dot is this raise, $3M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Other than the payment of salaries and other compensation and benefits no officer, director or promoter will receive any payments from the proceeds of this offering.
Martin Stanton is named as Director on the Form D that Mosaic Biosciences, Inc. filed with the SEC on 19 November 2026, one of 8 people that filing names.
Eric Furfine is named as Executive Officer and Director on the Form D that Mosaic Biosciences, Inc. filed with the SEC on 19 November 2026, one of 8 people that filing names.
Dan Mitchell is named as Director on the Form D that Mosaic Biosciences, Inc. filed with the SEC on 19 November 2026, one of 8 people that filing names.
Jeanette Welsh is named as Director on the Form D that Mosaic Biosciences, Inc. filed with the SEC on 19 November 2026, one of 8 people that filing names.
Rob Capone is named as Director on the Form D that Mosaic Biosciences, Inc. filed with the SEC on 19 November 2026, one of 8 people that filing names.
Jean-Pierre Wery is named as Executive Officer and Director on the Form D that Mosaic Biosciences, Inc. filed with the SEC on 19 November 2026, one of 8 people that filing names.
On the filing as: Director.
Deval Lashkari is named as Dr. Lashkari was elected a director in connection with the closing of the Offering. on the Form D that Mosaic Biosciences, Inc. filed with the SEC on 19 November 2026, one of 8 people that filing names.
Brooke Delgado is named as Executive Officer on the Form D that Mosaic Biosciences, Inc. filed with the SEC on 19 November 2026, one of 8 people that filing names.
8 people named on the filing — 3 holding an executive role and 5 as directors only.
Named as of the 2026-11-19 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Mosaic Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Mosaic Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Mosaic Biosciences, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
8 people named on this filing See who they are
Start a free 5-day trial →You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Mosaic Biosciences, Inc.You get an alert in MentionFox the next time this company shows up.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Mosaic Biosciences, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-11-16 · Biotech raises in Denver and Boulder
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/mosaic-biosciences-inc-form-d-000004